Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Portal Annular Pancreas: An Underrecognized Variant, Prevalence, and Clinical Relevance
 
Reetu John1, Betty Simon1, Anu Eapen1, Tharani Putta1, Philip Joseph2, Ravish Sanghi Raju2, Manbha L Rymbai2, Fredrick Vyas2
1Department of Radiodiagnosis, 2Department of Hepatopancreaticobiliary Surgery, Christian Medical College, Vellore, Tamil Nadu, India. 


Corresponding Author
:
Dr Betty Simon
Email: drbettysimon@gmail.com


Abstract

Background: The portal annular pancreas is a rare morphological variant where the pancreatic parenchyma encircles the portal vein or the superior mesenteric vein and fuses with the body of the pancreas. It may be mistaken for a pancreatic head mass and has grave implications for patients planned for pancreatic surgeries. 
Aim: This study aimed to determine the prevalence of portal annular pancreas in a cohort of patients attending a tertiary care referral centre in South India and to assess how frequently this was identified and reported in a routine CT scan report. 
Methods: A retrospective review of consecutive contrast-enhanced multi-detector computed tomography (MDCT) scans of the abdomen during the study period was used to assess for the presence of portal annular pancreas. It was classified into suprasplenic, infrasplenic, and mixed variants based on its relation to the splenoportal confluence. In addition, the radiology reports were reviewed with regard to mention of this variant. 
Results: The prevalence of portal annular pancreas in our study population was 25 out of 1000 patients (2.5%). There was an increased frequency of this anomaly in females; male: female ratio was 1:2.1. The most common morphological type was suprasplenic fusion. The portal annular pancreas was mentioned in only 1 out of 25 (4%) of the radiology reports. 
Conclusion: The prevalence of portal annular pancreas was 2.5% with a female preponderance in our series. This entity can be easily overlooked, and increased awareness would improve identification, thereby mitigating complications associated with pancreatic surgery.